VAM
IART icon

Visium Asset Management’s Integra LifeSciences IART Stock Holding History

Visium Asset Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-133,824
Closed -$2.57M – 1115
2014
Q2 		$2.57M Buy
+133,824
New +$2.49M 0.04% 353

Other funds holding IART

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Visium Asset Management's IART Position: Q3 2014 in Review

Visium Asset Management sold out of Integra LifeSciences (IART) in Q3 2014, closing a stake of 133,824 shares — an estimated $2.57M sold.

Visium Asset Management first reported a position in IART in Q2 2014 and held it in 1 quarter. The position peaked at $2.57M in Q2 2014. 143 funds tracked by Wall St. Rank hold IART as of Q3 2014.

  • Visium Asset Management reported no remaining Integra LifeSciences position as of Q3 2014 after selling out during the quarter.
  • Visium Asset Management sold 133,824 Integra LifeSciences shares in Q3 2014, an estimated $2.57M.
  • Visium Asset Management first reported a position in Integra LifeSciences in Q2 2014 and held it in 1 quarter.
  • Visium Asset Management's Integra LifeSciences position peaked at $2.57M in Q2 2014.
  • 143 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2014.

Based on Visium Asset Management's 13F filing for Q3 2014, filed 14 Nov 2014.